PhD, Research Director class 2 at CNRS, director of an INSERM team at the Center for Research in Transplantation and Immunology CRTI.
Dr. Ignacio ANEGONAdvisor
MD, Research Director class 1 at INSERM, Director of INSERM 1064 (2008-2018) and co-coordinator of team 2 “Induction of immunological tolerance”. Manager of the platform for genetically modified animals ” Rat Transgenesis and ImmunoPhenomic”.
Dr François-Xavier HUBERTPresident
MD, PhD in immunology. Advisor of international funding agencies and academic societies.
SCIENTIFIC ADVISORY BOARD
Roland BUELOW (PhD)
Founder and CEO of Teneobio (Palo Alto, USA). Successful serial entrepreneur, 35 years’ experience in the generation of MAbs.
Herman WALDMANN (MD)
Director Antibody Therapeutic Center of Oxford University. Developed Campath-1. 45 years of experience in translational and clinical immunology.
Hans-Dieter VOLK (MD)
Charité, University of Berlin, 35 years of experience in translational and clinical immunology.
Betty DIAMOND (MD)
Institute for Medical Research, NY, USA. 45 years of experience in lupus research.